# CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES

> **NIH NIH N01** · OREGON HEALTH & SCIENCE UNIVERSITY · 2020 · $9,657

## Abstract

There is a demand for new methods of contraception that can provide effective protection against 
unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for 
obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop 
protocols and conduct clinical trials that will assist in product development with the end goal to 
provide effective and safe contraception for women.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a 
mission to develop safe and effective contraceptives for women, including obese women and women who 
have medical conditions for which current
contraceptive products are contraindicated.

## Key facts

- **NIH application ID:** 10243576
- **Project number:** 75N94020D00016-0-759402000001-1
- **Recipient organization:** OREGON HEALTH & SCIENCE UNIVERSITY
- **Principal Investigator:** ALISON EDLMAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $9,657
- **Award type:** —
- **Project period:** 2020-08-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10243576

## Citation

> US National Institutes of Health, RePORTER application 10243576, CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES (75N94020D00016-0-759402000001-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10243576. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*